Fulgent Genetics: Buy Growth Ahead Below Liquidation Value [Seeking Alpha]
Fulgent Genetics, Inc. (FLGT)
Last fulgent genetics, inc. earnings: 3/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.fulgentgenetics.com
Company Research
Source: Seeking Alpha
The company is about to hit an inflection point, as 2024 will be the year revenues return to growth while margins expand. The Fulgent Pharma business acquired at the end of 2022 will remain a drag near term but offers significant mid- to long-term upside potential. With a liquidation value of $27.50 and a fair value of $40 per share, FLGT provides a rare low-risk, high-reward opportunity to investors with a 3-5 years investment horizon. Fulgent Genetics, Inc., ( NASDAQ: FLGT ) is a leading provider of comprehensive genetic testing solutions, offering an extensive suite of testing services to healthcare providers, researchers, and individuals, mainly in the United States. The company specializes in next-generation sequencing [NGS] technology, enabling the analysis of various genetic conditions and diseases with high accuracy and efficiency. With a focus on innovation and technology-driven solutions, Fulgent Genetics aims to empower healthcare professionals and patients with acti
Show less
Read more
Impact Snapshot
Event Time:
FLGT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FLGT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FLGT alerts
High impacting Fulgent Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
FLGT
News
- Fulgent Genetics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]Yahoo! Finance
- Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- Fulgent Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Fulgent Reports First Quarter 2024 Financial ResultsBusiness Wire
FLGT
Earnings
- 5/3/24 - Beat
FLGT
Sec Filings
- 5/7/24 - Form 4
- 5/7/24 - Form 4
- 5/3/24 - Form 4
- FLGT's page on the SEC website